Skip to content

Clinical trials

Phase 1 Central Nervous System Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Central Nervous System Neoplasms Phase: Phase 1 Clear all

207 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200010
20018
200216
20035
20049
200514
20069
200712
20089
20095
20104
20112
20123
20132
20142
20154
20163
20175
20187
20197
20205
20214
20222
20235
20242
20255
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed140
Terminated29
Recruiting11
Withdrawn10
Active, not recruiting8
Unknown status8
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)23
Children's Oncology Group14
Duke University13
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins12
Pediatric Brain Tumor Consortium10
Memorial Sloan Kettering Cancer Center7
St. Jude Children's Research Hospital7
Jonsson Comprehensive Cancer Center6
City of Hope Medical Center5
National Institutes of Health Clinical Center (CC)5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Central Nervous System Neoplasms207
Brain Neoplasms98
Astrocytoma93
Glioblastoma81
Gliosarcoma72
Oligodendroglioma68
Glioma57
Medulloblastoma51
Ependymoma36
Optic Nerve Glioma29

Trials

Showing 1 to 25 of 207. Each trial links to its page on Pharma Observatory.

107 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.